Teleflex buys airway device company; Baxter slapped with FDA warning letter;

 @FierceMedDev: Study: Balloon implant reduced rectal damage during prostate cancer treatment. Item | Follow @FierceMedDev

 @DamianFierce: Diagnostics companies gouged Medicare by almost $1B in 2011, according to the feds. Report | Follow @DamianFierce

 @MarkHFierce: We need your FMD Fierce 15 nominations. Submit them courtesy of this handy link: Nomination form | Follow @MarkHFierce

> Teleflex ($TFX) bought medical device outfit Ultimate Medical for an undisclosed sum, acquiring the company's line of airway management devices and laryngeal masks. More

> Sequenom ($SQNM) has cut the ribbon on a new CLIA-certified lab in North Carolina designed to help the company handle an increase in demand for its MaterniT21 Plus prenatal diagnostic. News

> Baxter ($BAX) received an FDA warning letter over mold and hair found at plants that make infusion sets. Article

> Startup Zuga Medical raised $250,000 to help launch its FDA-cleared dental surgery implant. Item

> ConvaTec received an FDA warning letter over how it manufactures some incontinence devices. Letter

> Diagnostics company HemoSonics has raised $1.3 million to develop a test that can detect life-threatening bleeding and blood clots. Story

> Minnesota's medical device industry is a bright spot in the state's otherwise tough climate for venture funding, according to National Venture Capital Association President Mark Heesen. Report

Biotech News

 @FierceBiotech: Firm tries startup's tech tricks for clinical trial recruitment. Article | Follow @FierceBiotech

 @JohnCFierce: Report stirs debate over the true impact of the genomics revolution. More | Follow @JohnCFierce

 @RyanMFierce: Add this AMG386 data to VTec results, and Amgen is 2 for 2 with Ph3 oncology programs this year. Devil's in the details, though. | Follow @RyanMFierce

 @EmilyMFierce: At a genomics briefing on the Hill. NIH Director Francis Collins says 25,000 jobs in biomedical research will be lost due to sequestration. | Follow @EmilyMFierce

> Celgene bolsters case for closely watched arthritis drug with Ph3 data. Story

> Amgen notches positive PhIII results for top cancer drug. Report

> Amgen's big Asian push triggers $75M heart drug pact for Japan. News

Pharma News

 @FiercePharma: Novartis acknowledges investigation of allegations of sales scheme in India, some employees have been fired. Story | Follow @FiercePharma

 @EricPFierce: ANSM in France says no problems found in Teva packaging of Furosemide product; tampering a possibility. More | Follow @EricPFierce

 @CarlyHFierce: Teva's at-risk launch of generic Protonix a bit riskier than it thought. Teva & Sun to pay $2.15B to Pfizer. Article | Follow @CarlyHFierce

> Cheaper generic combo found as effective in RA as blockbuster Enbrel. News

> Confab reviews safety of diabetes drugs like Merck's Januvia, Novo's Victoza. Article

> France finds no problems at Teva plant. More

Drug Delivery News

 @MichaelGFierce: Pearl's porous particle platform nets $1.15B AstraZeneca buyout. More | Follow @MichaelGFierce

> Ocular draws funding from Baxter to support hydrogel delivery platform. Item

> Origami inspires 3-D folded structures for drug delivery. Article

> New research further reveals nano-gold's delivery potential, safety risk. Story

Biomarkers News

> Heart experts link biomarkers with high risk of "silent strokes." Report

> Stunted telomeres might flag breast cancer risk. Article

> Genetic biomarker could help scientists select cell lines for stem cell studies. More

> Cancer Research UK, Abcodia to develop blood Dx attuned to early-stage cancers. Item

> Biomarker aids in gestational diabetes risk prediction. Story